Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats

Neuropathology

Volumn 33, Issue 5, 2013, Pages 505-514

  Sasaki, Atsushi ^a   Yokoo, Hideaki ^b   Tanaka, Yuko ^b   Homma, Taku ^a   Nakazato, Yoichi ^b   Ohgaki, Hiroko ^c  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Glioma; Microglia; Transgenic rats; Tumor associated macrophages; v erbB

Indexed keywords

CALCIUM BINDING PROTEIN; CD163 ANTIGEN; CHLORDANE; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; KI 67 ANTIGEN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; BLOOD VESSEL WALL; BRAIN TUMOR; CELL DEATH; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GLIOBLASTOMA; GLIOMA; IMMUNOHISTOCHEMISTRY; MACROPHAGE FUNCTION; MICROGLIA; MORPHOMETRICS; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR ASSOCIATED LEUKOCYTE;

GLIOMA; MICROGLIA; TRANSGENIC RATS; TUMOR-ASSOCIATED MACROPHAGES; V-ERBB;

ANIMALS; BRAIN NEOPLASMS; GLIOMA; MACROPHAGES; MICROGLIA; NEOPLASM INVASIVENESS; RATS; RATS, TRANSGENIC;

EID: 84884946778     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/neup.12015     Document Type: Article

References (53)

1. Horikoshi Y, Sasaki A, Taguchi M etal. Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections. Acta Neuropathol 2003; 105: 157-162.
2. Roberts ES, Masliah E, Fox HS. CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J Neuropathol Exp Neurol 2004; 63: 1255-1264.
3. Borda JT, Alvarez X, Mohan M etal. CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after hepatoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier. Am J Pathol 2008; 172: 725-737.
4. Graeber MB, Streit WJ, Kreutzberg GW. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res 1988; 21: 18-24.
5. Imai Y, Ibata I, Ito D etal. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996; 224: 855-862.
6. Ito D, Imai Y, Ohsawa K etal. Microglia-specific localization of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 1998; 57: 1-9.
7. Sasaki A, Horikoshi Y, Yokoo H etal. Antiserum against human glucose transporter 5(GLUT5) is highly specific for microglia within cells of the mononuclear phagocyte system. Neurosci Lett 2003; 338: 17-20.
8. Graeber MB, Streit WJ. Microglia: biology and pathology. Acta Neuropathol 2010; 119: 89-105.
9. Graeber MB, Fluegel A, Moran LB, Scheithauer BW. Immune biology of microglia in gliomas. In: Hagel C, Stavrou DK, eds. Immune Biology of Brain Tumours. Munchen-Orland: Dustri-Verlag Dr. Karl Feistle, 2010; 69-80.
10. Badie B, Schartner J. Role of microglia in glioma biology. Microsc Res Tech 2001; 54: 106-113.
11. Verhaak RGW, Hoadley KA, Purdom E etal. An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell 2010; 17: 98-110.
12. Badie B, Bartley B, Schartner J. Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas. J Neuroimmunol 2002; 133: 39-45.
13. Nakano Y, Kuroda E, Kito T etal. Induction of prostaglandin E2 synthesis and microsomal prostaglandin E synthetase-1 expression in murine microglia by glioma-derived soluble factors. J Neurosurg 2008; 108: 311-319.
14. Hong TM, Teng LJ, Shun CT etal. Induced interleukin-8 expression in gliomas by tumor-associated macrophages. J Neurooncol 2009; 93: 289-301.
15. Mantovani A, Sozzani S, Locati M etal. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-555.
16. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
17. Komohara Y, Ohnishi K, Kuratsu J etal. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008; 216: 15-24.
18. Morioka T, Baba T, Black KL etal. Response of microglial cells to experimental rat glioma. Glia 1992; 6: 75-79.
19. Wang SC, Hong JH, Hsueh C etal. Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab Invest 2012; 92: 151-162.
20. Weiss WA, Burns MJ, Hackett C etal. Genetic determinants of malignancy in a mouse model for oligodendrogliom. Cancer Res 2003; 63: 1589-1595.
21. Ohgaki H, Kita D, Favereaux A etal. Brain tumors in S100β-v-erbB transgenic rats. J Neuropathol Exp Neurol 2006; 65: 1111-1117.
22. Yokoo H, Tanaka Y, Nobusawa S etal. Immunohistochemical and ultrastructural characterization of brain tumors in S100b-v-erbB transgenic rats. Neuropathology 2008; 28: 591-598.
23. Graeber MB, Scheithauer BW, Kreutzberg GW. Microglia in brain tumors. Glia 2002; 40: 252-259.
24. Roggendorf W, Strupp S, Paulus W. Distribution and characterization of microglia/macrophages in human braintumors. Acta Neuropathol 1996; 92: 288-293.
25. Sasaki A, Tamura M, Hasegawa M etal. Expression of interleukin-1β mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry. J Neuropathol Exp Neurol 1998; 57: 653-663.
26. Nishie A, Ono M, Shono T etal. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 1999; 5: 1107-1113.
27. Sasaki A, Ishiuchi S, Kanda T etal. Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenograpfts, and glioblastoma cell lines. Brain Tumor Pathol 2001; 18: 13-21.
28. Sasaki A, Yamaguchi H, Horikoshi Y etal. Expression of glucose transporter 5 by microglia in human gliomas. Neuropathol Appl Neurobiol 2004; 30: 447-455.
29. Badie B, Schartner J, Prabakaran S etal. Expression of Fas ligand by microglia: possible role in glioma immune evasion. J Neuroimmunol 2001; 120: 19-24.
30. Bettinger I, Thanos S, Paulus W. Microglia promote glioma migration. Acta Neuropathol 2002; 103: 351-355.
31. Kostianovsky AM, Maier LM, Anderson RC etal. Astrocytic regulation of human monocytic/microglial activation. J Immunol 2008; 181: 5425-5432.
32. Schartner JM, Hagar AR, Van Handel M etal. Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Glia 2005; 51: 279-285.
33. Galarneau H, Villeneuve J, Gowing G etal. Increased glioma growth in mice depleted of macrophages. Cancer Res 2007; 67: 8874-8881.
34. Platten M, Kretz A, Naumann U etal. Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 2003; 54: 388-392.
35. Okada M, Saio M, Kito Y etal. Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. Int J Oncol 2009; 34: 1621-1627.
36. Badie B, Schartner J, Klaver J etal. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 1999; 44: 1077-1082.
37. Morris CS, Esiri MM. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease.1. Gliomas. J Neurol Sci 1991; 101: 47-58.
38. Paulus W, Roggendorf W, Kirchner T. Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues. Acta Neuropathol 1992; 84: 538-544.
39. Morimura T, Neuchrist C, Kitz K etal. Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation. Acta Neuropathol 1990; 80: 287-294.
40. Yamamoto S, Nakajima K, Kohsaka S. Macropjhage-colony stimulating factor as an inducer of microglial proliferation in axotomized rat facial nucleus. J Neurochem 2010; 115: 1057-1067.
41. DeNardo DG, Barreto JB, Andreu P etal. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumoral properties of macrophages. Cancer Cell 2009; 16: 91-102.
42. Andreu P, Johansson M, Affara NI etal. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 2010; 17: 121-134.
43. Wesseling P, Schlingemann RO, Rietveld FJ etal. Early and extensive contribution of pericyte/vascular smooth muscle cells to microvascular proliferation in glioblastoma multiforme: an immune-light and immune-electron microscopic study. J Neuropathol Exp Neurol 1995; 54: 304-310.
44. Iwamoto FM, Fine HA. Bevacizumab for malignant gliomas. Arch Neurol 2010; 67: 285-288.
45. Kerber M, Reiss Y, Wickersheim A etal. Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res 2008; 68: 7342-7351.
46. Forstreuter F, Lucius R, Mentlein R. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 2002; 132: 93-98.
47. Deininger MH, Meyermann R, Trautmann K etal. cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression. Brain Res 2000; 885: 111-116.
48. Zhang Z, Zhang ZY, Wu Y etal. Lesional accumulation of CD163+ macrophages/microglia in rat traumatic brain injury. Brain Res 2012; 1461: 102-110.
49. Stout RD, Jiang C, Matta B etal. Macrophagea sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005; 175: 342-349.
50. Chiang CS, Chen FH, Hong JH etal. Functional phenotype of macropages depends on assay procedures. Int Immunol 2008; 20: 215-222.
51. Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G etal. Classical and alternative activationof mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 2006; 211: 487-501.
52. Umemura N, Saio M, Suwa T etal. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics. J Leukoc Biol 2008; 83: 1136-1144.
53. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007; 117: 1155-1166.